Columbia University's Zuckerman Institute
Columbia’s Zuckerman Institute is dedicated to sharing the extraordinary research of our scientists with broad audiences.
https://zuckermaninstitute.columbia.edu/
https://zuckermaninstitute.columbia.edu/
Remdesivir vs. 3CLpro Inhibitor in SARS-CoV-2 Battle: Does 3CL Protease Inhibitor Have Superior Efficacy Compared to Remdesivir?
By
Columbia University's Zuckerman Institute
FEATURING
Meike Dittmann
By
Columbia University's Zuckerman Institute
FEATURING
Meike Dittmann
Login to view comments.
Click here to Login
